Since the establishment of high content imaging for high throughput screening, the evolution of a number of technologies has changed imaging. The emergence of new technologies, both label free and with labels (QPI, SRM, structured Illumination) are enabling the scientist to address ever more complex biological question. In addition, combinations of technologies such as Correlative Light Electron Microscopy are driving more specialized applications. At the same time, the mobile revolution is enabling very user friendly, easy to use instrumentation and user interfaces. Also, the emergence of cloud based data storage and applications is creating an ecosystem of data sharing, as well as standardization of methods. The opportunities and challenges to address this complex applications space from a commercial perspective will be discussed.
Christoph Hergersberg, Michael O'Grady, Paul Boeschoten, and Nicholas Radio, "Enabling new imaging technology: simplicity and complex questions in the commercial setting (Conference Presentation)," Proc. SPIE 10503, Quantitative Phase Imaging IV, 105030Z (Presented at SPIE BiOS: January 29, 2018; Published: 15 March 2018); https://doi.org/10.1117/12.2316497.5752161042001.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the proceedings. They include the speaker's narration with video of the slides and animations. Most include full-text papers. Interactive, searchable transcripts and closed captioning are now available for most presentations.
Search our growing collection of more than 25,000 conference presentations, including many plenaries and keynotes.
Glassy 2-(1-benzyl-2-styryl-6-methylpyridin-4(1H)-ylidene) fragment containing 1H-indene-1,3(2H)-dione and pyrimidine-2,4,6(1H,3H,5H)-trione derivatives with light-emitting and amplified spontaneous emission properties